Market Cap 109.53M
Revenue (ttm) 490,000.00
Net Income (ttm) -51.42M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -10,493.88%
Debt to Equity Ratio 0.00
Volume 242,500
Avg Vol 501,328
Day's Range N/A - N/A
Shares Out 30.68M
Stochastic %K 49%
Beta 0.55
Analysts Strong Sell
Price Target $13.00

Company Profile

Vistagen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development and commercialization of therapies for neuropsychiatric and neurological disorders. The company's product pipeline includes Fasedienol, an investigational pherine nasal spray that is in Phase III clinical trial for the treatment of anxiety in adults with social anxiety disorder; and Itruvone, an odorless synthetic investigational neuroactive pherine nasal spray, which is in Phase II clinical trial...

Industry: Biotechnology
Sector: Healthcare
Phone: 650 577 3600
Address:
343 Allerton Avenue, South San Francisco, United States
Grace528
Grace528 Sep. 11 at 11:16 PM
$VTGN Today-9/11/25 And just like that , the biggest insiders (directors ☺️) of #VTGN $VTGN are offered to excercise a buy in the future at a lower price (today’s price) until 2035. Time to LOAD UP. Form 4 was filed for 4-5 directors .They entered at $3.61, I entered at $2.47. So they (insiders) entered at $1.20 higher than me. Exactly how Chatgpt says: Institutionals in biopharma stocks enter 3 months ago (on average) before moonshot. Insiders enter 1 month ago before skyrockets. So Nov 25? If you are invested, it’s always a good habit to subscribe to the actual stock’s email from the actual company. They will inform you with all the Sec filings, meetings, conferences. Directors are the biggest insiders, they know the ins and outs of the actual product, the business model, the books and financials. The form 4 basically tells you, hey we (directors) know exactly how this product is doing and we r ok to get the right to buy this cheap when it skyrockets
1 · Reply
To_De_Moon
To_De_Moon Sep. 11 at 8:13 PM
0 · Reply
magman111
magman111 Sep. 11 at 6:41 PM
$VTGN Volume will probably stay low, until they announce “last patient”
1 · Reply
Stmkr
Stmkr Sep. 11 at 2:37 PM
$VTGN Is this too cheap or am I missing sth??
0 · Reply
RajivD
RajivD Sep. 11 at 12:18 PM
0 · Reply
Sondre
Sondre Sep. 11 at 12:06 PM
0 · Reply
Halg_fr
Halg_fr Sep. 10 at 2:12 PM
$VTGN 3 weeks until Q4…
1 · Reply
Don_Wick
Don_Wick Sep. 9 at 4:28 PM
$VTGN Good or bad news?
1 · Reply
To_De_Moon
To_De_Moon Sep. 9 at 4:07 PM
$VTGN news today?
0 · Reply
BioBum
BioBum Sep. 9 at 3:30 PM
$VTGN the fact that pal 1 was horsehit, they stopped pal 2, told themselves we need to look at what we are fucking up on, educated their team on protocols and pal 2 was successful— means SOMETHING. We have the drug performing similarly in both trials, and a HUGE placebo response in pal 1. Placebo response was mitigated in pal 2. I would think it had to do with the team locking down on protocols.
1 · Reply
Latest News on VTGN
Vistagen to Participate in Stifel 2025 Virtual CNS Forum

Mar 4, 2025, 8:30 AM EST - 6 months ago

Vistagen to Participate in Stifel 2025 Virtual CNS Forum


Vistagen to Present at the Stifel 2024 Healthcare Conference

Nov 14, 2024, 8:30 AM EST - 10 months ago

Vistagen to Present at the Stifel 2024 Healthcare Conference


Vistagen to Present at Stifel 2024 Virtual CNS Days

Mar 11, 2024, 8:30 AM EDT - 1 year ago

Vistagen to Present at Stifel 2024 Virtual CNS Days


Grace528
Grace528 Sep. 11 at 11:16 PM
$VTGN Today-9/11/25 And just like that , the biggest insiders (directors ☺️) of #VTGN $VTGN are offered to excercise a buy in the future at a lower price (today’s price) until 2035. Time to LOAD UP. Form 4 was filed for 4-5 directors .They entered at $3.61, I entered at $2.47. So they (insiders) entered at $1.20 higher than me. Exactly how Chatgpt says: Institutionals in biopharma stocks enter 3 months ago (on average) before moonshot. Insiders enter 1 month ago before skyrockets. So Nov 25? If you are invested, it’s always a good habit to subscribe to the actual stock’s email from the actual company. They will inform you with all the Sec filings, meetings, conferences. Directors are the biggest insiders, they know the ins and outs of the actual product, the business model, the books and financials. The form 4 basically tells you, hey we (directors) know exactly how this product is doing and we r ok to get the right to buy this cheap when it skyrockets
1 · Reply
To_De_Moon
To_De_Moon Sep. 11 at 8:13 PM
0 · Reply
magman111
magman111 Sep. 11 at 6:41 PM
$VTGN Volume will probably stay low, until they announce “last patient”
1 · Reply
Stmkr
Stmkr Sep. 11 at 2:37 PM
$VTGN Is this too cheap or am I missing sth??
0 · Reply
RajivD
RajivD Sep. 11 at 12:18 PM
0 · Reply
Sondre
Sondre Sep. 11 at 12:06 PM
0 · Reply
Halg_fr
Halg_fr Sep. 10 at 2:12 PM
$VTGN 3 weeks until Q4…
1 · Reply
Don_Wick
Don_Wick Sep. 9 at 4:28 PM
$VTGN Good or bad news?
1 · Reply
To_De_Moon
To_De_Moon Sep. 9 at 4:07 PM
$VTGN news today?
0 · Reply
BioBum
BioBum Sep. 9 at 3:30 PM
$VTGN the fact that pal 1 was horsehit, they stopped pal 2, told themselves we need to look at what we are fucking up on, educated their team on protocols and pal 2 was successful— means SOMETHING. We have the drug performing similarly in both trials, and a HUGE placebo response in pal 1. Placebo response was mitigated in pal 2. I would think it had to do with the team locking down on protocols.
1 · Reply
Charbar16
Charbar16 Sep. 9 at 2:28 PM
$VTGN In reviewing the Palisades 1 trial failure and all of the information available I believe the single most important variable in Vistagen achieving positive results in Palisades 3 is their ability through study design and inclusion/exclusion criteria to contain the variability in the placebo group response. VistaGen has explicitly emphasized that controlling the placebo response is critical for PALISADE-3’s success. In this trial, only very high-severity SAD patients are enrolled – specifically, those with a Liebowitz Social Anxiety Scale (LSAS) score ≥ 70 at screening. Major psychiatric comorbidities and any current anxiety treatments are excluded. For example, the protocol bars patients from being on psychotropic medications, ongoing CBT/exposure therapy, or even OTC/alternative anxiety remedies within 30 days of treatment.
2 · Reply
Heroforest
Heroforest Sep. 9 at 1:05 AM
$VTGN $VTGN they mentioned that the top line results will be ready 6 weeks to 8 weeks after last Patient visit. Have they announced last patient visit yet? Thanks
2 · Reply
Sorted_Details
Sorted_Details Sep. 8 at 6:28 PM
$VTGN Well now we who drove this up last month. Janus Henderson Biotech Innovation Master Fund bought up 4.1m shares. They are now 14% owners of the company. What is remarkable to me is that represents about 33% of the effective float, yet the price didn't spike as much as you would expect. There were a lot of sellers into that accumulation. Still, this position represents less than a drop in the bucket for this fund, just .01% of their holdings. I would have rather seen more broad based buying. This is very low stakes flyer, of the sort this fund has been making for years. Make of it what you will. It's not NOT bullish, but it's not really anything in my opinion. Low stakes flyer on a company that was at the time trading at book value close to a readout. I expect some de-risking between now and readout.
1 · Reply
Stockrunner54
Stockrunner54 Sep. 8 at 5:28 PM
$VTGN vanguard/janus Henderson, increasing their stake to a whopping 13+% ??? Someone is confident !
0 · Reply
mb0157
mb0157 Sep. 8 at 5:16 PM
$VTGN. Nice to see!!
0 · Reply
Haimalon
Haimalon Sep. 8 at 1:58 PM
$VTGN This beauty is sleeping
1 · Reply
NVDAMillionaire
NVDAMillionaire Sep. 8 at 12:15 PM
$VTGN Brilliant piece that captures VTGN's situation perfectly. So if you want to update your understanding of VTGN or get to know VTGN better, this is essential reading. https://beyondspx.com/quote/VTGN/analysis/the-pherine-frontier-vistagen-s-bid-for-acute-sad-leadership-and-beyond-nasdaq-vtgn
0 · Reply
Stockrunner54
Stockrunner54 Sep. 7 at 8:46 PM
$VTGN are you ready for October?
0 · Reply
MakesHerSquirt
MakesHerSquirt Sep. 5 at 11:15 PM
$VTGN Dip incoming don't listen to the pumpers. I'll wait ro add. GOODLUCK
2 · Reply
Stockrunner54
Stockrunner54 Sep. 5 at 3:22 PM
$VTGN no dip this time boys. It’s stuck to the upper band me thinks.
0 · Reply
Ruzmadji
Ruzmadji Sep. 5 at 2:47 PM
$VTGN woohoo! LMAO Let me in at $3.45
0 · Reply
Stockrunner54
Stockrunner54 Sep. 5 at 1:46 PM
$VTGN no guts no glory!
0 · Reply